Honokiol Extract
- Specification: 10:1 /Honokiol2%- 98%
- Appearance: Brown to white fine powder
- Part used: Root
- Sample: 10-20g Available
- Our certification: ISO, HACCP, Organic, HALAL, KOSHER, SC
- Shelf Life: 2 years
- Delivery Time: 7-15 days
- OEM&ODM: Powder, capsule, tablet, liquid form
- Our Packing: 25kg/barrel, 10kg/25kg/Carton, 1kg/5kg/10kg/bag or your request
Product Details
Honokiol extract powder is derived from the Magnolia dried root, which is the dried bark, root bark and branch bark of Magnolia officinalis or other Magnolia officinalis. It likes to be born in a warm and humid climate and well-drained acidic soil, and it grows in the woods on the foothills of hillsides and roadsides and streams.
Magnolia officinalis is bitter, pungent and warm in nature, and belongs to the spleen, stomach, lung and large intestine meridians. Honokiol extract powder is mainly used in health food nutrition supplements, personal care cosmetics feed additives, pharmaceutical and other fields.
What we offer are:
- Magnolia bark extract powder 10:1 20:1 50:1
- Magnolol2%- 98%
- Total phenol(Magnolol+Honokiol)2%-98%
- Dihydrohonkial-b (DHH-B) 98%
- Tetrahydramagnolol (THM) 98%
Health Benefits
- Anti-inflammatoryHonokiol at higher concentrations inhibited the activity of COX in disrupted cells, while inhibiting the LO metabolic pathway. Therefore, honokiol is a dual inhibitor of COX and LO.
- AntioxidantHonokiol can protect the activity of mitochondrial respiratory chain enzymes against NADPH-induced peroxidative stress, antagonize the oxidative hemolysis of red blood cells, and inhibit lipid peroxidation.
- Antibacterial effectIt have strong antibacterial effect on cariogenic bacteria Streptococcus mutans (Streptococus matuans), and its antibacterial active ingredients are determined to be magnolol and honokiol.
- Inhibitory effect of platelet aggregation. Honokiol and honokiol inhibit collagen and arachidonic acid-induced aggregation and ATP release of rabbit platelet-rich plasma, and the aggregation of washed platelets is more significantly inhibited than that of platelet-rich plasma. Aggregation of whole blood was less affected by these two inhibitors.
* This statement for educational purposes only. It has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.